{
}
Janus Henderson Group plc is a UK-based independent global asset manager that specializes in active investing across various asset classes, including Equities, Fixed Income, Multi-Asset, and Alternatives. The firm offers a wide range of investment products for institutional and private investors through multiple channels, including intermediaries and direct retail services. With a global presence, Janus Henderson operates offices in North America, Europe, Latin America, Asia, and Australia.
Otsuka Pharmaceutical's experimental drug, sibeprenlimab, has shown promising results in a Phase 3 trial for IgA nephropathy, a rare kidney disease, demonstrating a significant reduction in protein levels in urine, a key indicator of kidney health. The company plans to discuss accelerated approval with the FDA while the trial continues, expected to conclude in early 2026. This development validates Otsuka's acquisition of Visterra, which focuses on immune diseases, and positions sibeprenlimab as a potential first-in-class treatment for IgAN.
The global convergence in healthcare market is projected to grow from $126.2 billion in 2023 to $304.5 billion by 2031, with a CAGR of 11.78%. North America leads this market due to its advanced healthcare infrastructure, while Europe is expected to experience the fastest growth driven by rising coronary artery disease rates. Recent innovations include real-time health monitoring systems and integrated patient monitoring solutions from major companies like Philips and Honeywell.
Apple Inc. focuses on designing, manufacturing, and marketing computer hardware and music media, with telephony products, primarily the iPhone, accounting for 52.3% of sales. Other segments include peripherals (10.4%), computers (7.7%), music media (7.4%), and various services (22.2%). Geographically, sales are led by the Americas (42.4%), followed by Europe-India-Middle East-Africa (24.7%) and China-Hong Kong-Taiwan (18.9%).
Apple Inc. focuses on designing, manufacturing, and marketing computer hardware and music support products. Its net sales are primarily driven by telephone products, particularly the iPhone, which accounts for 52.1% of revenue, followed by peripheral devices, computers, and music support. Geographically, sales are strongest in the Americas, followed by Europe and Asia.
UBS has maintained a "Neutral" rating for Apple, setting a target price of $236. Analyst David Vogt noted that weak customer figures from Verizon indicate a potential decline in iPhone demand. Apple's revenue is primarily driven by phone products, which account for over 52% of net sales.
The International Monetary Fund has raised its 2024 growth forecast for the UK to 1.1%, up from 0.7%, citing lower inflation and interest rates as key factors boosting domestic demand. Inflation fell to 1.7% in September, down from 11.1% a year prior, prompting expectations of quicker interest rate cuts by the Bank of England. As the Labour Party prepares to unveil its first budget in 14 years, Prime Minister Keir Starmer warns of "tough" decisions to address a claimed £22 billion financing shortfall.
The EU has approved a loan of up to €35 billion to Ukraine as part of a broader G7 initiative to provide $50 billion in support for the war-affected economy by year-end. The loan will be repaid using profits from over €250 billion of Russian assets frozen in Western banks since February 2022. While the U.K. and Canada have pledged $3 billion and $3.6 billion respectively, the U.S. and Japan's contributions remain unclear, with the U.S. indicating a willingness to participate despite ongoing sanctions discussions.
Coherent Market Insights offers a comprehensive analysis of the Healthcare Staffing Market, detailing service types, regional segmentation, and key market indicators. The report evaluates market dynamics, competitive strategies, and growth forecasts through 2031, providing valuable insights for stakeholders across various sectors.
Coherent Market Insights, a global market intelligence firm headquartered in India, provides critical insights across various sectors, focusing on transformational growth for clients in over 57 countries. Their latest report on the Temporary Healthcare Staffing Market analyzes trends, forecasts, and competitive strategies, highlighting key players and regional growth potential from 2024 to 2031. The research aims to empower stakeholders with data-driven insights for informed decision-making in a post-COVID-19 landscape.
JPN
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
janus henderson group maintains neutral stance according to ubs analysis
17:14 22.10.2024
otsuka's kidney disease drug shows promise in phase 3 trial results
Travere Therapeutics, Inc.
Biogen Inc.
Q32 Bio Inc.
Otsuka Pharmaceutical Co. Ltd.
Calliditas Therapeutics AB (publ)
Vera Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated
Novartis AG
JPN
USA
Brian Pereira
John Kraus
Show more
16:51 22.10.2024
global healthcare convergence market projected to reach 304.5 billion by 2031
United States Dollar
Koninklijke Philips N.V.
GE HealthCare Technologies Inc.
Honeywell International Inc.
BioSig Technologies, Inc. Common Stock
USA
BRA
IND
KOR
ESP
ZAF
MEX
FRA
GBR
CAN
ITA
JPN
DEU
CHN
ARG
Koninklijke Philips N.V.
Honeywell International Inc.
InsightAce Analytic
Inc.
GE Healthcare
PreXion
Show more
16:15 22.10.2024
apple inc maintains neutral stance as product sales diversify globally
15:46 22.10.2024
apple inc maintains neutral rating with diverse product sales distribution
15:46 22.10.2024
ubs maintains neutral rating on apple with target price of 236 dollars
15:45 22.10.2024
IMF raises UK growth forecast amid declining inflation and interest rates
Euro
United States Dollar
British Pound Sterling
Japanese Yen
S&P Global Inc.
Bank of England
JPN
DEU
GBR
CAN
USA
Keir Starmer
Rachel Reeves
Show more
15:02 22.10.2024
eu approves 35 billion loan to support ukraine's economy amid g7 initiative
Ukrainian Hryvnia
United States Dollar
Euro
Russian Ruble
Apple Inc.
Hungary Enbi Ltd.
Air Canada
Russia
U.K. B&P Ltd.
JPN
RUS
UKR
CAN
USA
Show more
12:54 22.10.2024
healthcare staffing market analysis trends and future growth insights
United States Dollar
Adecco Group AG
Maxim Healthcare Group
AMN Healthcare Services, Inc.
Cross Country Healthcare, Inc.
Envision Healthcare Corporation
NGA
IND
ZAF
RUS
COL
JPN
GBR
ARE
CAN
CHN
BRA
ARG
KOR
USA
MEX
DEU
FRA
ITA
EGY
SAU
Alice Mutum
Mr. Shah
Show more
12:15 22.10.2024
temporary healthcare staffing market insights and growth forecasts for 2024 to 2031
United States Dollar
Coherent Market Insights
NGA
IND
ZAF
RUS
COL
JPN
GBR
ARE
CAN
CHN
BRA
ARG
KOR
USA
MEX
DEU
FRA
ITA
EGY
SAU
Alice Mutum
Show more
12:05 22.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Finance Mergers & Acquisitions
Global Financial Events
CEO Changes
Retail and Consumer Goods
Banking Regulations
Market Analysis and Predictions
Industry Mergers & Acquisitions
Global Trade Developments
Energy Sector Developments
Startups & Entrepreneurship
Government Policies
Supply Chain Management
Financial Scams and Security
Domestic Politics
Government Economic Policies
Central Bank Actions
Hedge Funds & Private Equity
Countries:
Companies:
Tesla, Inc.
Barclays PLC
JPMorgan Chase & Co.
Apple Inc.
BNP Paribas SA
UBS Group AG
NVIDIA Corporation
Morgan Stanley
Bank of America Corporation
Capital One Financial Corporation
The Goldman Sachs Group, Inc.
Deutsche Bank RV Global PP
Amazon.com, Inc.
Citigroup Inc.
Commerzbank AG
SpaceXCoin USD
Credit Suisse Real Estate Fund Siat
Wells Fargo & Company
UniCredit S.p.A.
Microsoft Corporation
Currencies:
United States Dollar
Euro
Chinese Yuan
Indian Rupee
Swiss Franc
British Pound Sterling
Vietnamese Đồng
Hong Kong Dollar
Australian Dollar
United Arab Emirates Dirham
Singapore Dollar
South Korean Won
Thai Baht
Norwegian Krone
Danish Krone
Swedish Krona
Russian Ruble
Ghanaian Cedi
Canadian Dollar
Turkish Lira
People: